Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Quantitative mpMRI to Predict Metastatic Potential of Prostate Cancer

NCT05252806 is registered in ClinicalTrials.gov with Radboud University Medical Center as lead sponsor.

NCT NCT05252806
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05252806 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Quantitative mpMRI to Predict Metastatic Potential of Prostate Cancer
Lead sponsor
Radboud University Medical Center
Phase
Observational
Overall status
Unknown status
Start date
July 31, 2022
Completion date
March 31, 2023
Enrollment
30 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

prostate cancer